Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

374 ARTÍCULOS , VIENDO DEL 181 AL 195

Targeting Neuroinflammation to Treat Alzheimer's Disease

Ardura-Fabregat A, Boddeke EWGM, Boza-Serrano A, Brioschi S, Castro-Gomez S, Ceyzériat K, Dansokho C, Dierkes T, Gelders G, Heneka MT, Hoeijmakers L, Hoffmann A, Iaccarino L, Jahnert S, Kuhbandner K, Landreth G, Lonnemann N, Löschmann PA, McManus RM, Paulus A, Reemst K, Sanchez-Caro JM, Tiberi A, Van der Perren A, Vautheny A, Venegas C, Webers A, Weydt P, Wijasa TS, Xiang X, Yang Y.

CNS Drugs. 2017 Dec;31(12):1057-1082. doi: 10.1007/s40263-017-0483-3.

Nasal steroids as a possible treatment for Alzheimer's disease

Lehrer S, Rheinstein PH.

Discov Med. 2017 Oct;24(132):147-152.

Drug discovery, development and delivery in Alzheimer's disease

Brambilla D.

Pharm Res. 2017 Dec 29;35(1):3. doi: 10.1007/s11095-017-2329-6.

P-glycoprotein (ABCB1) and Oxidative Stress: Focus on Alzheimer's Disease

Sita G, Hrelia P, Tarozzi A, Morroni F.

Oxid Med Cell Longev. 2017;2017:7905486. doi: 10.1155/2017/7905486. Epub 2017 Nov 26.

Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules

Umar T, Hoda N.

Curr Top Med Chem. 2017;17(31):3370-3389. doi: 10.2174/1568026618666180112161024.

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

Rampa A, Gobbi S, Concetta Di Martino RM, Belluti F, Bisi A.

Curr Top Med Chem. 2017;17(31):3361-3369. doi: 10.2174/1568026618666180112161406.

Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease

Ismaili L, do Carmo Carreiras M.

Curr Top Med Chem. 2017;17(31):3319-3327. doi: 10.2174/1568026618666180112155424.

New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines

Oset-Gasque MJ, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3349-3360. doi: 10.2174/1568026618666180112155928.

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

Romero A, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3328-3335. doi: 10.2174/1568026618666180112155639.

Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics

Chakraborty S.

Curr Top Med Chem. 2017;17(31):3336-3348. doi: 10.2174/1568026618666180116122921.

Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry

Garcia-Ptacek S, Modéer IN, Kåreholt I, Fereshtehnejad SM, Farahmand B, Religa D, Eriksdotter M.

Age Ageing. 2017 Mar 1;46(2):314-319. doi: 10.1093/ageing/afw189.

A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland

Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D.

Drugs Aging. 2017 Jan;34(1):55-65. doi: 10.1007/s40266-016-0419-5.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer's Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients

Blanco-Silvente L, Castells X, Saez M, Barceló MA, Garre-Olmo J, Vilalta-Franch J, Capellà D.

Int J Neuropsychopharmacol. 2017 Jul 1;20(7):519-528. doi: 10.1093/ijnp/pyx012.

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial

Campbell NL, Perkins AJ, Gao S, Skaar TC, Li L, Hendrie HC, Fowler N, Callahan CM, Boustani MA.

J Am Geriatr Soc. 2017 Jul;65(7):1497-1504. doi: 10.1111/jgs.14827. Epub 2017 Mar 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias